Infinity Clinical Laboratory Absecon, NJ - 08205

Infinity Clinical Laboratory is categorized under Testing Laboratories in Absecon, NJ and active since 2012.

Infinity Clinical Laboratory was established in 2012, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 72 West Jimmie Leeds Road, Absecon, New Jersey NJ 08205 or by phoning (609) 652-7212. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Infinity Clinical Laboratory
Address: 72 West Jimmie Leeds Road, Absecon, New Jersey 08205
Phone Number: (609) 652-7212
Website Address: myinfinitylabs.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Testing Laboratories
SIC Code: 8734
NAICS Code: 6215110
Share This Business:

Infinity Clinical Laboratory was started in 2012 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact for inquiries that concern Infinity Clinical Laboratory by calling the company number (609) 652-7212, as your correspondence is most welcome. Additionally, the physical location of the single location of Infinity Clinical Laboratory can be found at the coordinates 39.47662,-74.54202 as well as the street address 72 West Jimmie Leeds Road in Absecon, New Jersey 08205.

For its online presence, you may visit Infinity Clinical Laboratory’s website at myinfinitylabs.com and engage with its social media outlets through on Twitter and on Facebook.